Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept

被引:38
作者
Yamauchi, PS [1 ]
Lowe, NJ [1 ]
Gindi, V [1 ]
机构
[1] Clin Res Specialists, Santa Monica, CA 90404 USA
关键词
D O I
10.1016/j.jaad.2005.10.055
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:S121 / S122
页数:2
相关论文
共 7 条
[1]  
Ameglio F, 1998, BRIT J DERMATOL, V138, P611
[2]  
Berookhim B, 2004, CUTIS, V74, P245
[3]  
D'Auria L, 1999, EUR CYTOKINE NETW, V10, P123
[4]  
Lin MH, 2005, ARCH DERMATOL, V141, P680, DOI 10.1001/archderm.141.6.680
[5]   The immunology of psoriasis and biologic immunotherapy [J].
Mehlis, SL ;
Gordon, KB .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (02) :S44-S50
[6]  
Rhodes LE, 1999, ACTA DERM-VENEREOL, V79, P288
[7]   Treatment of recalcitrant cicatricial pemphigoid with the tumor necrosis factor α antagonist etanercept [J].
Sacher, C ;
Rubbert, A ;
König, C ;
Scharffetter-Kochanek, K ;
Krieg, T ;
Hunzelmann, N .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (01) :113-115